カテゴリー： 世界, 医療/バイオ, LP Information

世界の血液がん検出装置市場予測 2023年-2029年

【英語タイトル】Global Blood Cancer Detection Market Growth 2023-2029

LP Informationが出版した調査資料（LP23DC03166）・商品コード：LP23DC03166
・発行会社（調査会社）：LP Information
・発行日：2023年11月
・ページ数：123
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後2-3営業日）
・調査対象地域：グローバル、日本、アメリカ、ヨーロッパ、アジア、中国など
・産業分野：医療機器＆消耗品
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,660 ⇒換算￥556,320見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,490 ⇒換算￥834,480見積依頼/購入/質問フォーム
Corporate User（閲覧人数制限なし）USD7,320 ⇒換算￥1,112,640見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
❖ レポートの概要 ❖

LPインフォメーションの最新刊調査レポート「世界の血液がん検出装置市場」は、過去の販売実績から2022年の世界の血液がん検出装置の総販売量を検討し、2023年から2029年の予測される血液がん検出装置の販売量を地域別・市場分野別に包括的に分析しています。本調査レポートでは、地域別、市場分野別、サブセクター別の血液がん検出装置の市場規模を掲載し、XXX百万米ドル規模の世界の血液がん検出装置市場の詳細な分析を提供します。本インサイトレポートは、世界の血液がん検出装置業界を包括的に分析し、製品セグメント、企業情報、売上、市場シェア、最新動向、M&A活動に関する主要トレンドを明らかにしています。
また、本レポートでは、加速する世界の血液がん検出装置市場における各社の独自のポジションをより深く理解するために、血液がん検出装置製品ポートフォリオ、能力、市場参入戦略、市場でのポジション、海外展開に焦点を当て、主要なグローバル企業の戦略を分析しています。

世界の血液がん検出装置市場規模は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに成長すると予測され、2023年から2029年までの年平均成長率は000%と予測されます。血液がん検出装置の米国市場は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加し、2023年から2029年までのCAGRは000％と予測されています。血液がん検出装置の中国市場は、2023年から2029年までの年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されます。血液がん検出装置のヨーロッパ市場は、2023年から2029年にかけて年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されています。

血液がん検出装置の世界主要メーカーとしては、Abbott Laboratories、 F.Hoffman-LaRoche、 QIAGEN、 Thermo Fisher Scientific、 lllumina、 Bio-Rad Laboratories、 MolecularMD、 ArcherDX、 ARUP Laboratories、 Asuragen、 Invivoscribe、 Adaptive、Biotechnologies、 Amoy Diagnostics、 ELITechGroup、 VelaDiagnostics、 Gentronix、 BiolVT、 SAGA Diagnostics、 Olink、 Cancer Diagnosticsなどを掲載しており、売上の面では、世界の2大企業が2022年にほぼ000％のシェアを占めています。

本レポートでは、製品タイプ、用途、主要メーカー、主要地域、国別の血液がん検出装置市場の包括的な概要、市場シェア、成長機会などの情報を提供しています。

【市場細分化】

この調査では血液がん検出装置市場をセグメンテーションし、種類別 (サーブ、検出キット)、用途別 (臨床検査、病院、学術研究機関、その他)、および地域別 (アジア太平洋、南北アメリカ、ヨーロッパ、および中東・アフリカ) の市場規模を予測しています。

・種類別区分：サーブ、検出キット

・用途別区分：臨床検査、病院、学術研究機関、その他

・地域別区分
南北アメリカ（アメリカ、カナダ、メキシコ、ブラジル）
アジア太平洋（中国、日本、韓国、東南アジア、インド、オーストラリア）
ヨーロッパ（ドイツ、フランス、イギリス、イタリア、ロシア）
中東・アフリカ（エジプト、南アフリカ、イスラエル、トルコ、GCC諸国）

【本レポートで扱う主な質問】

・世界の血液がん検出装置市場の10年間の市場状況・展望は？
・世界および地域別に見た血液がん検出装置市場成長の要因は何か？
・血液がん検出装置の市場機会はエンドマーケットの規模によってどのように変化するのか？
・血液がん検出装置のタイプ別、用途別の内訳は？
・新型コロナウイルス感染症とロシア・ウクライナ戦争の影響は？

********* 目次 *********

レポートの範囲
・市場の紹介
・分析対象期間
・調査の目的
・調査手法
・調査プロセスおよびデータソース
・経済指標
・通貨

エグゼクティブサマリー
・世界市場の概要：血液がん検出装置の年間販売量2018-2029、地域別現状・将来分析
・血液がん検出装置の種類別セグメント：サーブ、検出キット
・血液がん検出装置の種類別販売量：2018-2023年の販売量、売上、市場シェア、販売価格
・血液がん検出装置の用途別セグメント：臨床検査、病院、学術研究機関、その他
・血液がん検出装置の用途別販売量：2018-2023年の販売量、売上、市場シェア、販売価格

企業別世界の血液がん検出装置市場
・企業別のグローバル血液がん検出装置市場データ：2018-2023年の年間販売量、市場シェア
・企業別の血液がん検出装置の年間売上：2018-2023年の売上、市場シェア
・企業別の血液がん検出装置販売価格
・主要企業の血液がん検出装置生産地域、販売地域、製品タイプ
・市場集中度分析
・新製品および潜在的な参加者
・合併と買収、拡大

血液がん検出装置の地域別レビュー
・地域別の血液がん検出装置市場規模2018-2023：年間販売量、売上
・主要国別の血液がん検出装置市場規模2018-2023：年間販売量、売上
・南北アメリカの血液がん検出装置販売の成長
・アジア太平洋の血液がん検出装置販売の成長
・ヨーロッパの血液がん検出装置販売の成長
・中東・アフリカの血液がん検出装置販売の成長

南北アメリカ市場
・南北アメリカの国別の血液がん検出装置販売量、売上（2018-2023）
・南北アメリカの血液がん検出装置の種類別販売量
・南北アメリカの血液がん検出装置の用途別販売量
・アメリカ市場
・カナダ市場
・メキシコ市場
・ブラジル市場

アジア太平洋市場
・アジア太平洋の国別の血液がん検出装置販売量、売上（2018-2023）
・アジア太平洋の血液がん検出装置の種類別販売量
・アジア太平洋の血液がん検出装置の用途別販売量
・中国市場
・日本市場
・韓国市場
・東南アジア市場
・インド市場
・オーストラリア市場
・台湾市場

ヨーロッパ市場
・ヨーロッパの国別の血液がん検出装置販売量、売上（2018-2023）
・ヨーロッパの血液がん検出装置の種類別販売量
・ヨーロッパの血液がん検出装置の用途別販売量
・ドイツ市場
・フランス市場
・イギリス市場
・イタリア市場
・ロシア市場

中東・アフリカ市場
・中東・アフリカの国別の血液がん検出装置販売量、売上（2018-2023）
・中東・アフリカの血液がん検出装置の種類別販売量
・中東・アフリカの血液がん検出装置の用途別販売量
・エジプト市場
・南アフリカ市場
・イスラエル市場
・トルコ市場
・GCC諸国市場

市場の成長要因、課題、動向
・市場の成長要因および成長機会分析
・市場の課題およびリスク
・市場動向

製造コスト構造分析
・原材料とサプライヤー
・血液がん検出装置の製造コスト構造分析
・血液がん検出装置の製造プロセス分析
・血液がん検出装置の産業チェーン構造

マーケティング、販売業者および顧客
・販売チャンネル：直接販売チャンネル、間接販売チャンネル
・血液がん検出装置の主要なグローバル販売業者
・血液がん検出装置の主要なグローバル顧客

地域別の血液がん検出装置市場予測レビュー
・地域別の血液がん検出装置市場規模予測（2024-2029）
・南北アメリカの国別予測
・アジア太平洋の国別予測
・ヨーロッパの国別予測
・血液がん検出装置の種類別市場規模予測
・血液がん検出装置の用途別市場規模予測

主要企業分析
Abbott Laboratories、 F.Hoffman-LaRoche、 QIAGEN、 Thermo Fisher Scientific、 lllumina、 Bio-Rad Laboratories、 MolecularMD、 ArcherDX、 ARUP Laboratories、 Asuragen、 Invivoscribe、 Adaptive、Biotechnologies、 Amoy Diagnostics、 ELITechGroup、 VelaDiagnostics、 Gentronix、 BiolVT、 SAGA Diagnostics、 Olink、 Cancer Diagnostics
・企業情報
・血液がん検出装置製品
・血液がん検出装置販売量、売上、価格、粗利益（2018-2023）
・主要ビジネス概要
・最新動向

調査結果および結論

The global Blood Cancer Detection market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Blood Cancer Detection is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Blood Cancer Detection is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Blood Cancer Detection is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Blood Cancer Detection players cover Abbott Laboratories, F.Hoffman-LaRoche, QIAGEN, Thermo Fisher Scientific, lllumina, Bio-Rad Laboratories, MolecularMD, ArcherDX and ARUP Laboratories, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
Diagnosis of hematological tumors is the analysis and diagnosis of tumors using blood
LPI (LP Information)’ newest research report, the “Blood Cancer Detection Industry Forecast” looks at past sales and reviews total world Blood Cancer Detection sales in 2022, providing a comprehensive analysis by region and market sector of projected Blood Cancer Detection sales for 2023 through 2029. With Blood Cancer Detection sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Blood Cancer Detection industry.
This Insight Report provides a comprehensive analysis of the global Blood Cancer Detection landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Blood Cancer Detection portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Blood Cancer Detection market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Blood Cancer Detection and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Blood Cancer Detection.
This report presents a comprehensive overview, market shares, and growth opportunities of Blood Cancer Detection market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Serve
Detection Kit
Segmentation by application
Clinical Laboratory
Hospital
Academic Research Institution
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company’s coverage, product portfolio, its market penetration.
Abbott Laboratories
F.Hoffman-LaRoche
QIAGEN
Thermo Fisher Scientific
lllumina
Bio-Rad Laboratories
MolecularMD
ArcherDX
ARUP Laboratories
Asuragen
Invivoscribe
Adaptive
Biotechnologies
Amoy Diagnostics
ELITechGroup
VelaDiagnostics
Gentronix
BiolVT
SAGA Diagnostics
Olink
Cancer Diagnostics
Key Questions Addressed in this Report
What is the 10-year outlook for the global Blood Cancer Detection market?
What factors are driving Blood Cancer Detection market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Blood Cancer Detection market opportunities vary by end market size?
How does Blood Cancer Detection break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?

❖ レポートの目次 ❖

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Blood Cancer Detection Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Blood Cancer Detection by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Blood Cancer Detection by Country/Region, 2018, 2022 & 2029
2.2 Blood Cancer Detection Segment by Type
2.2.1 Serve
2.2.2 Detection Kit
2.3 Blood Cancer Detection Sales by Type
2.3.1 Global Blood Cancer Detection Sales Market Share by Type (2018-2023)
2.3.2 Global Blood Cancer Detection Revenue and Market Share by Type (2018-2023)
2.3.3 Global Blood Cancer Detection Sale Price by Type (2018-2023)
2.4 Blood Cancer Detection Segment by Application
2.4.1 Clinical Laboratory
2.4.2 Hospital
2.4.3 Academic Research Institution
2.4.4 Other
2.5 Blood Cancer Detection Sales by Application
2.5.1 Global Blood Cancer Detection Sale Market Share by Application (2018-2023)
2.5.2 Global Blood Cancer Detection Revenue and Market Share by Application (2018-2023)
2.5.3 Global Blood Cancer Detection Sale Price by Application (2018-2023)
3 Global Blood Cancer Detection by Company
3.1 Global Blood Cancer Detection Breakdown Data by Company
3.1.1 Global Blood Cancer Detection Annual Sales by Company (2018-2023)
3.1.2 Global Blood Cancer Detection Sales Market Share by Company (2018-2023)
3.2 Global Blood Cancer Detection Annual Revenue by Company (2018-2023)
3.2.1 Global Blood Cancer Detection Revenue by Company (2018-2023)
3.2.2 Global Blood Cancer Detection Revenue Market Share by Company (2018-2023)
3.3 Global Blood Cancer Detection Sale Price by Company
3.4 Key Manufacturers Blood Cancer Detection Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Blood Cancer Detection Product Location Distribution
3.4.2 Players Blood Cancer Detection Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Blood Cancer Detection by Geographic Region
4.1 World Historic Blood Cancer Detection Market Size by Geographic Region (2018-2023)
4.1.1 Global Blood Cancer Detection Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Blood Cancer Detection Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Blood Cancer Detection Market Size by Country/Region (2018-2023)
4.2.1 Global Blood Cancer Detection Annual Sales by Country/Region (2018-2023)
4.2.2 Global Blood Cancer Detection Annual Revenue by Country/Region (2018-2023)
4.3 Americas Blood Cancer Detection Sales Growth
4.4 APAC Blood Cancer Detection Sales Growth
4.5 Europe Blood Cancer Detection Sales Growth
4.6 Middle East & Africa Blood Cancer Detection Sales Growth
5 Americas
5.1 Americas Blood Cancer Detection Sales by Country
5.1.1 Americas Blood Cancer Detection Sales by Country (2018-2023)
5.1.2 Americas Blood Cancer Detection Revenue by Country (2018-2023)
5.2 Americas Blood Cancer Detection Sales by Type
5.3 Americas Blood Cancer Detection Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Blood Cancer Detection Sales by Region
6.1.1 APAC Blood Cancer Detection Sales by Region (2018-2023)
6.1.2 APAC Blood Cancer Detection Revenue by Region (2018-2023)
6.2 APAC Blood Cancer Detection Sales by Type
6.3 APAC Blood Cancer Detection Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Blood Cancer Detection by Country
7.1.1 Europe Blood Cancer Detection Sales by Country (2018-2023)
7.1.2 Europe Blood Cancer Detection Revenue by Country (2018-2023)
7.2 Europe Blood Cancer Detection Sales by Type
7.3 Europe Blood Cancer Detection Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Blood Cancer Detection by Country
8.1.1 Middle East & Africa Blood Cancer Detection Sales by Country (2018-2023)
8.1.2 Middle East & Africa Blood Cancer Detection Revenue by Country (2018-2023)
8.2 Middle East & Africa Blood Cancer Detection Sales by Type
8.3 Middle East & Africa Blood Cancer Detection Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Blood Cancer Detection
10.3 Manufacturing Process Analysis of Blood Cancer Detection
10.4 Industry Chain Structure of Blood Cancer Detection
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Blood Cancer Detection Distributors
11.3 Blood Cancer Detection Customer
12 World Forecast Review for Blood Cancer Detection by Geographic Region
12.1 Global Blood Cancer Detection Market Size Forecast by Region
12.1.1 Global Blood Cancer Detection Forecast by Region (2024-2029)
12.1.2 Global Blood Cancer Detection Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Blood Cancer Detection Forecast by Type
12.7 Global Blood Cancer Detection Forecast by Application
13 Key Players Analysis
13.1 Abbott Laboratories
13.1.1 Abbott Laboratories Company Information
13.1.2 Abbott Laboratories Blood Cancer Detection Product Portfolios and Specifications
13.1.3 Abbott Laboratories Blood Cancer Detection Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Abbott Laboratories Main Business Overview
13.1.5 Abbott Laboratories Latest Developments
13.2 F.Hoffman-LaRoche
13.2.1 F.Hoffman-LaRoche Company Information
13.2.2 F.Hoffman-LaRoche Blood Cancer Detection Product Portfolios and Specifications
13.2.3 F.Hoffman-LaRoche Blood Cancer Detection Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 F.Hoffman-LaRoche Main Business Overview
13.2.5 F.Hoffman-LaRoche Latest Developments
13.3 QIAGEN
13.3.1 QIAGEN Company Information
13.3.2 QIAGEN Blood Cancer Detection Product Portfolios and Specifications
13.3.3 QIAGEN Blood Cancer Detection Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 QIAGEN Main Business Overview
13.3.5 QIAGEN Latest Developments
13.4 Thermo Fisher Scientific
13.4.1 Thermo Fisher Scientific Company Information
13.4.2 Thermo Fisher Scientific Blood Cancer Detection Product Portfolios and Specifications
13.4.3 Thermo Fisher Scientific Blood Cancer Detection Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Thermo Fisher Scientific Main Business Overview
13.4.5 Thermo Fisher Scientific Latest Developments
13.5 lllumina
13.5.1 lllumina Company Information
13.5.2 lllumina Blood Cancer Detection Product Portfolios and Specifications
13.5.3 lllumina Blood Cancer Detection Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 lllumina Main Business Overview
13.5.5 lllumina Latest Developments
13.6 Bio-Rad Laboratories
13.6.1 Bio-Rad Laboratories Company Information
13.6.2 Bio-Rad Laboratories Blood Cancer Detection Product Portfolios and Specifications
13.6.3 Bio-Rad Laboratories Blood Cancer Detection Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Bio-Rad Laboratories Main Business Overview
13.6.5 Bio-Rad Laboratories Latest Developments
13.7 MolecularMD
13.7.1 MolecularMD Company Information
13.7.2 MolecularMD Blood Cancer Detection Product Portfolios and Specifications
13.7.3 MolecularMD Blood Cancer Detection Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 MolecularMD Main Business Overview
13.7.5 MolecularMD Latest Developments
13.8 ArcherDX
13.8.1 ArcherDX Company Information
13.8.2 ArcherDX Blood Cancer Detection Product Portfolios and Specifications
13.8.3 ArcherDX Blood Cancer Detection Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 ArcherDX Main Business Overview
13.8.5 ArcherDX Latest Developments
13.9 ARUP Laboratories
13.9.1 ARUP Laboratories Company Information
13.9.2 ARUP Laboratories Blood Cancer Detection Product Portfolios and Specifications
13.9.3 ARUP Laboratories Blood Cancer Detection Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 ARUP Laboratories Main Business Overview
13.9.5 ARUP Laboratories Latest Developments
13.10 Asuragen
13.10.1 Asuragen Company Information
13.10.2 Asuragen Blood Cancer Detection Product Portfolios and Specifications
13.10.3 Asuragen Blood Cancer Detection Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Asuragen Main Business Overview
13.10.5 Asuragen Latest Developments
13.11 Invivoscribe
13.11.1 Invivoscribe Company Information
13.11.2 Invivoscribe Blood Cancer Detection Product Portfolios and Specifications
13.11.3 Invivoscribe Blood Cancer Detection Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Invivoscribe Main Business Overview
13.11.5 Invivoscribe Latest Developments
13.12 Adaptive
Biotechnologies
13.12.1 Adaptive
Biotechnologies Company Information
13.12.2 Adaptive
Biotechnologies Blood Cancer Detection Product Portfolios and Specifications
13.12.3 Adaptive
Biotechnologies Blood Cancer Detection Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Adaptive
Biotechnologies Main Business Overview
13.12.5 Adaptive
Biotechnologies Latest Developments
13.13 Amoy Diagnostics
13.13.1 Amoy Diagnostics Company Information
13.13.2 Amoy Diagnostics Blood Cancer Detection Product Portfolios and Specifications
13.13.3 Amoy Diagnostics Blood Cancer Detection Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 Amoy Diagnostics Main Business Overview
13.13.5 Amoy Diagnostics Latest Developments
13.14 ELITechGroup
13.14.1 ELITechGroup Company Information
13.14.2 ELITechGroup Blood Cancer Detection Product Portfolios and Specifications
13.14.3 ELITechGroup Blood Cancer Detection Sales, Revenue, Price and Gross Margin (2018-2023)
13.14.4 ELITechGroup Main Business Overview
13.14.5 ELITechGroup Latest Developments
13.15 VelaDiagnostics
13.15.1 VelaDiagnostics Company Information
13.15.2 VelaDiagnostics Blood Cancer Detection Product Portfolios and Specifications
13.15.3 VelaDiagnostics Blood Cancer Detection Sales, Revenue, Price and Gross Margin (2018-2023)
13.15.4 VelaDiagnostics Main Business Overview
13.15.5 VelaDiagnostics Latest Developments
13.16 Gentronix
13.16.1 Gentronix Company Information
13.16.2 Gentronix Blood Cancer Detection Product Portfolios and Specifications
13.16.3 Gentronix Blood Cancer Detection Sales, Revenue, Price and Gross Margin (2018-2023)
13.16.4 Gentronix Main Business Overview
13.16.5 Gentronix Latest Developments
13.17 BiolVT
13.17.1 BiolVT Company Information
13.17.2 BiolVT Blood Cancer Detection Product Portfolios and Specifications
13.17.3 BiolVT Blood Cancer Detection Sales, Revenue, Price and Gross Margin (2018-2023)
13.17.4 BiolVT Main Business Overview
13.17.5 BiolVT Latest Developments
13.18 SAGA Diagnostics
13.18.1 SAGA Diagnostics Company Information
13.18.2 SAGA Diagnostics Blood Cancer Detection Product Portfolios and Specifications
13.18.3 SAGA Diagnostics Blood Cancer Detection Sales, Revenue, Price and Gross Margin (2018-2023)
13.18.4 SAGA Diagnostics Main Business Overview
13.18.5 SAGA Diagnostics Latest Developments
13.19 Olink
13.19.1 Olink Company Information
13.19.2 Olink Blood Cancer Detection Product Portfolios and Specifications
13.19.3 Olink Blood Cancer Detection Sales, Revenue, Price and Gross Margin (2018-2023)
13.19.4 Olink Main Business Overview
13.19.5 Olink Latest Developments
13.20 Cancer Diagnostics
13.20.1 Cancer Diagnostics Company Information
13.20.2 Cancer Diagnostics Blood Cancer Detection Product Portfolios and Specifications
13.20.3 Cancer Diagnostics Blood Cancer Detection Sales, Revenue, Price and Gross Margin (2018-2023)
13.20.4 Cancer Diagnostics Main Business Overview
13.20.5 Cancer Diagnostics Latest Developments
14 Research Findings and Conclusion

List of Tables
Table 1. Blood Cancer Detection Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Blood Cancer Detection Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Serve
Table 4. Major Players of Detection Kit
Table 5. Global Blood Cancer Detection Sales by Type (2018-2023) & (K Units)
Table 6. Global Blood Cancer Detection Sales Market Share by Type (2018-2023)
Table 7. Global Blood Cancer Detection Revenue by Type (2018-2023) & ($ million)
Table 8. Global Blood Cancer Detection Revenue Market Share by Type (2018-2023)
Table 9. Global Blood Cancer Detection Sale Price by Type (2018-2023) & (US$/Unit)
Table 10. Global Blood Cancer Detection Sales by Application (2018-2023) & (K Units)
Table 11. Global Blood Cancer Detection Sales Market Share by Application (2018-2023)
Table 12. Global Blood Cancer Detection Revenue by Application (2018-2023)
Table 13. Global Blood Cancer Detection Revenue Market Share by Application (2018-2023)
Table 14. Global Blood Cancer Detection Sale Price by Application (2018-2023) & (US$/Unit)
Table 15. Global Blood Cancer Detection Sales by Company (2018-2023) & (K Units)
Table 16. Global Blood Cancer Detection Sales Market Share by Company (2018-2023)
Table 17. Global Blood Cancer Detection Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Blood Cancer Detection Revenue Market Share by Company (2018-2023)
Table 19. Global Blood Cancer Detection Sale Price by Company (2018-2023) & (US$/Unit)
Table 20. Key Manufacturers Blood Cancer Detection Producing Area Distribution and Sales Area
Table 21. Players Blood Cancer Detection Products Offered
Table 22. Blood Cancer Detection Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Blood Cancer Detection Sales by Geographic Region (2018-2023) & (K Units)
Table 26. Global Blood Cancer Detection Sales Market Share Geographic Region (2018-2023)
Table 27. Global Blood Cancer Detection Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Blood Cancer Detection Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Blood Cancer Detection Sales by Country/Region (2018-2023) & (K Units)
Table 30. Global Blood Cancer Detection Sales Market Share by Country/Region (2018-2023)
Table 31. Global Blood Cancer Detection Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Blood Cancer Detection Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Blood Cancer Detection Sales by Country (2018-2023) & (K Units)
Table 34. Americas Blood Cancer Detection Sales Market Share by Country (2018-2023)
Table 35. Americas Blood Cancer Detection Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Blood Cancer Detection Revenue Market Share by Country (2018-2023)
Table 37. Americas Blood Cancer Detection Sales by Type (2018-2023) & (K Units)
Table 38. Americas Blood Cancer Detection Sales by Application (2018-2023) & (K Units)
Table 39. APAC Blood Cancer Detection Sales by Region (2018-2023) & (K Units)
Table 40. APAC Blood Cancer Detection Sales Market Share by Region (2018-2023)
Table 41. APAC Blood Cancer Detection Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Blood Cancer Detection Revenue Market Share by Region (2018-2023)
Table 43. APAC Blood Cancer Detection Sales by Type (2018-2023) & (K Units)
Table 44. APAC Blood Cancer Detection Sales by Application (2018-2023) & (K Units)
Table 45. Europe Blood Cancer Detection Sales by Country (2018-2023) & (K Units)
Table 46. Europe Blood Cancer Detection Sales Market Share by Country (2018-2023)
Table 47. Europe Blood Cancer Detection Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Blood Cancer Detection Revenue Market Share by Country (2018-2023)
Table 49. Europe Blood Cancer Detection Sales by Type (2018-2023) & (K Units)
Table 50. Europe Blood Cancer Detection Sales by Application (2018-2023) & (K Units)
Table 51. Middle East & Africa Blood Cancer Detection Sales by Country (2018-2023) & (K Units)
Table 52. Middle East & Africa Blood Cancer Detection Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Blood Cancer Detection Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Blood Cancer Detection Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Blood Cancer Detection Sales by Type (2018-2023) & (K Units)
Table 56. Middle East & Africa Blood Cancer Detection Sales by Application (2018-2023) & (K Units)
Table 57. Key Market Drivers & Growth Opportunities of Blood Cancer Detection
Table 58. Key Market Challenges & Risks of Blood Cancer Detection
Table 59. Key Industry Trends of Blood Cancer Detection
Table 60. Blood Cancer Detection Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Blood Cancer Detection Distributors List
Table 63. Blood Cancer Detection Customer List
Table 64. Global Blood Cancer Detection Sales Forecast by Region (2024-2029) & (K Units)
Table 65. Global Blood Cancer Detection Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Blood Cancer Detection Sales Forecast by Country (2024-2029) & (K Units)
Table 67. Americas Blood Cancer Detection Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Blood Cancer Detection Sales Forecast by Region (2024-2029) & (K Units)
Table 69. APAC Blood Cancer Detection Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Blood Cancer Detection Sales Forecast by Country (2024-2029) & (K Units)
Table 71. Europe Blood Cancer Detection Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Blood Cancer Detection Sales Forecast by Country (2024-2029) & (K Units)
Table 73. Middle East & Africa Blood Cancer Detection Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Blood Cancer Detection Sales Forecast by Type (2024-2029) & (K Units)
Table 75. Global Blood Cancer Detection Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Blood Cancer Detection Sales Forecast by Application (2024-2029) & (K Units)
Table 77. Global Blood Cancer Detection Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. Abbott Laboratories Basic Information, Blood Cancer Detection Manufacturing Base, Sales Area and Its Competitors
Table 79. Abbott Laboratories Blood Cancer Detection Product Portfolios and Specifications
Table 80. Abbott Laboratories Blood Cancer Detection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 81. Abbott Laboratories Main Business
Table 82. Abbott Laboratories Latest Developments
Table 83. F.Hoffman-LaRoche Basic Information, Blood Cancer Detection Manufacturing Base, Sales Area and Its Competitors
Table 84. F.Hoffman-LaRoche Blood Cancer Detection Product Portfolios and Specifications
Table 85. F.Hoffman-LaRoche Blood Cancer Detection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 86. F.Hoffman-LaRoche Main Business
Table 87. F.Hoffman-LaRoche Latest Developments
Table 88. QIAGEN Basic Information, Blood Cancer Detection Manufacturing Base, Sales Area and Its Competitors
Table 89. QIAGEN Blood Cancer Detection Product Portfolios and Specifications
Table 90. QIAGEN Blood Cancer Detection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 91. QIAGEN Main Business
Table 92. QIAGEN Latest Developments
Table 93. Thermo Fisher Scientific Basic Information, Blood Cancer Detection Manufacturing Base, Sales Area and Its Competitors
Table 94. Thermo Fisher Scientific Blood Cancer Detection Product Portfolios and Specifications
Table 95. Thermo Fisher Scientific Blood Cancer Detection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 96. Thermo Fisher Scientific Main Business
Table 97. Thermo Fisher Scientific Latest Developments
Table 98. lllumina Basic Information, Blood Cancer Detection Manufacturing Base, Sales Area and Its Competitors
Table 99. lllumina Blood Cancer Detection Product Portfolios and Specifications
Table 100. lllumina Blood Cancer Detection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 101. lllumina Main Business
Table 102. lllumina Latest Developments
Table 103. Bio-Rad Laboratories Basic Information, Blood Cancer Detection Manufacturing Base, Sales Area and Its Competitors
Table 104. Bio-Rad Laboratories Blood Cancer Detection Product Portfolios and Specifications
Table 105. Bio-Rad Laboratories Blood Cancer Detection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 106. Bio-Rad Laboratories Main Business
Table 107. Bio-Rad Laboratories Latest Developments
Table 108. MolecularMD Basic Information, Blood Cancer Detection Manufacturing Base, Sales Area and Its Competitors
Table 109. MolecularMD Blood Cancer Detection Product Portfolios and Specifications
Table 110. MolecularMD Blood Cancer Detection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 111. MolecularMD Main Business
Table 112. MolecularMD Latest Developments
Table 113. ArcherDX Basic Information, Blood Cancer Detection Manufacturing Base, Sales Area and Its Competitors
Table 114. ArcherDX Blood Cancer Detection Product Portfolios and Specifications
Table 115. ArcherDX Blood Cancer Detection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 116. ArcherDX Main Business
Table 117. ArcherDX Latest Developments
Table 118. ARUP Laboratories Basic Information, Blood Cancer Detection Manufacturing Base, Sales Area and Its Competitors
Table 119. ARUP Laboratories Blood Cancer Detection Product Portfolios and Specifications
Table 120. ARUP Laboratories Blood Cancer Detection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 121. ARUP Laboratories Main Business
Table 122. ARUP Laboratories Latest Developments
Table 123. Asuragen Basic Information, Blood Cancer Detection Manufacturing Base, Sales Area and Its Competitors
Table 124. Asuragen Blood Cancer Detection Product Portfolios and Specifications
Table 125. Asuragen Blood Cancer Detection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 126. Asuragen Main Business
Table 127. Asuragen Latest Developments
Table 128. Invivoscribe Basic Information, Blood Cancer Detection Manufacturing Base, Sales Area and Its Competitors
Table 129. Invivoscribe Blood Cancer Detection Product Portfolios and Specifications
Table 130. Invivoscribe Blood Cancer Detection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 131. Invivoscribe Main Business
Table 132. Invivoscribe Latest Developments
Table 133. Adaptive
Biotechnologies Basic Information, Blood Cancer Detection Manufacturing Base, Sales Area and Its Competitors
Table 134. Adaptive
Biotechnologies Blood Cancer Detection Product Portfolios and Specifications
Table 135. Adaptive
Biotechnologies Blood Cancer Detection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 136. Adaptive
Biotechnologies Main Business
Table 137. Adaptive
Biotechnologies Latest Developments
Table 138. Amoy Diagnostics Basic Information, Blood Cancer Detection Manufacturing Base, Sales Area and Its Competitors
Table 139. Amoy Diagnostics Blood Cancer Detection Product Portfolios and Specifications
Table 140. Amoy Diagnostics Blood Cancer Detection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 141. Amoy Diagnostics Main Business
Table 142. Amoy Diagnostics Latest Developments
Table 143. ELITechGroup Basic Information, Blood Cancer Detection Manufacturing Base, Sales Area and Its Competitors
Table 144. ELITechGroup Blood Cancer Detection Product Portfolios and Specifications
Table 145. ELITechGroup Blood Cancer Detection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 146. ELITechGroup Main Business
Table 147. ELITechGroup Latest Developments
Table 148. VelaDiagnostics Basic Information, Blood Cancer Detection Manufacturing Base, Sales Area and Its Competitors
Table 149. VelaDiagnostics Blood Cancer Detection Product Portfolios and Specifications
Table 150. VelaDiagnostics Blood Cancer Detection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 151. VelaDiagnostics Main Business
Table 152. VelaDiagnostics Latest Developments
Table 153. Gentronix Basic Information, Blood Cancer Detection Manufacturing Base, Sales Area and Its Competitors
Table 154. Gentronix Blood Cancer Detection Product Portfolios and Specifications
Table 155. Gentronix Blood Cancer Detection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 156. Gentronix Main Business
Table 157. Gentronix Latest Developments
Table 158. BiolVT Basic Information, Blood Cancer Detection Manufacturing Base, Sales Area and Its Competitors
Table 159. BiolVT Blood Cancer Detection Product Portfolios and Specifications
Table 160. BiolVT Blood Cancer Detection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 161. BiolVT Main Business
Table 162. BiolVT Latest Developments
Table 163. SAGA Diagnostics Basic Information, Blood Cancer Detection Manufacturing Base, Sales Area and Its Competitors
Table 164. SAGA Diagnostics Blood Cancer Detection Product Portfolios and Specifications
Table 165. SAGA Diagnostics Blood Cancer Detection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 166. SAGA Diagnostics Main Business
Table 167. SAGA Diagnostics Latest Developments
Table 168. Olink Basic Information, Blood Cancer Detection Manufacturing Base, Sales Area and Its Competitors
Table 169. Olink Blood Cancer Detection Product Portfolios and Specifications
Table 170. Olink Blood Cancer Detection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 171. Olink Main Business
Table 172. Olink Latest Developments
Table 173. Cancer Diagnostics Basic Information, Blood Cancer Detection Manufacturing Base, Sales Area and Its Competitors
Table 174. Cancer Diagnostics Blood Cancer Detection Product Portfolios and Specifications
Table 175. Cancer Diagnostics Blood Cancer Detection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 176. Cancer Diagnostics Main Business
Table 177. Cancer Diagnostics Latest Developments
List of Figures
Figure 1. Picture of Blood Cancer Detection
Figure 2. Blood Cancer Detection Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Blood Cancer Detection Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Blood Cancer Detection Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Blood Cancer Detection Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Serve
Figure 10. Product Picture of Detection Kit
Figure 11. Global Blood Cancer Detection Sales Market Share by Type in 2022
Figure 12. Global Blood Cancer Detection Revenue Market Share by Type (2018-2023)
Figure 13. Blood Cancer Detection Consumed in Clinical Laboratory
Figure 14. Global Blood Cancer Detection Market: Clinical Laboratory (2018-2023) & (K Units)
Figure 15. Blood Cancer Detection Consumed in Hospital
Figure 16. Global Blood Cancer Detection Market: Hospital (2018-2023) & (K Units)
Figure 17. Blood Cancer Detection Consumed in Academic Research Institution
Figure 18. Global Blood Cancer Detection Market: Academic Research Institution (2018-2023) & (K Units)
Figure 19. Blood Cancer Detection Consumed in Other
Figure 20. Global Blood Cancer Detection Market: Other (2018-2023) & (K Units)
Figure 21. Global Blood Cancer Detection Sales Market Share by Application (2022)
Figure 22. Global Blood Cancer Detection Revenue Market Share by Application in 2022
Figure 23. Blood Cancer Detection Sales Market by Company in 2022 (K Units)
Figure 24. Global Blood Cancer Detection Sales Market Share by Company in 2022
Figure 25. Blood Cancer Detection Revenue Market by Company in 2022 ($ Million)
Figure 26. Global Blood Cancer Detection Revenue Market Share by Company in 2022
Figure 27. Global Blood Cancer Detection Sales Market Share by Geographic Region (2018-2023)
Figure 28. Global Blood Cancer Detection Revenue Market Share by Geographic Region in 2022
Figure 29. Americas Blood Cancer Detection Sales 2018-2023 (K Units)
Figure 30. Americas Blood Cancer Detection Revenue 2018-2023 ($ Millions)
Figure 31. APAC Blood Cancer Detection Sales 2018-2023 (K Units)
Figure 32. APAC Blood Cancer Detection Revenue 2018-2023 ($ Millions)
Figure 33. Europe Blood Cancer Detection Sales 2018-2023 (K Units)
Figure 34. Europe Blood Cancer Detection Revenue 2018-2023 ($ Millions)
Figure 35. Middle East & Africa Blood Cancer Detection Sales 2018-2023 (K Units)
Figure 36. Middle East & Africa Blood Cancer Detection Revenue 2018-2023 ($ Millions)
Figure 37. Americas Blood Cancer Detection Sales Market Share by Country in 2022
Figure 38. Americas Blood Cancer Detection Revenue Market Share by Country in 2022
Figure 39. Americas Blood Cancer Detection Sales Market Share by Type (2018-2023)
Figure 40. Americas Blood Cancer Detection Sales Market Share by Application (2018-2023)
Figure 41. United States Blood Cancer Detection Revenue Growth 2018-2023 ($ Millions)
Figure 42. Canada Blood Cancer Detection Revenue Growth 2018-2023 ($ Millions)
Figure 43. Mexico Blood Cancer Detection Revenue Growth 2018-2023 ($ Millions)
Figure 44. Brazil Blood Cancer Detection Revenue Growth 2018-2023 ($ Millions)
Figure 45. APAC Blood Cancer Detection Sales Market Share by Region in 2022
Figure 46. APAC Blood Cancer Detection Revenue Market Share by Regions in 2022
Figure 47. APAC Blood Cancer Detection Sales Market Share by Type (2018-2023)
Figure 48. APAC Blood Cancer Detection Sales Market Share by Application (2018-2023)
Figure 49. China Blood Cancer Detection Revenue Growth 2018-2023 ($ Millions)
Figure 50. Japan Blood Cancer Detection Revenue Growth 2018-2023 ($ Millions)
Figure 51. South Korea Blood Cancer Detection Revenue Growth 2018-2023 ($ Millions)
Figure 52. Southeast Asia Blood Cancer Detection Revenue Growth 2018-2023 ($ Millions)
Figure 53. India Blood Cancer Detection Revenue Growth 2018-2023 ($ Millions)
Figure 54. Australia Blood Cancer Detection Revenue Growth 2018-2023 ($ Millions)
Figure 55. China Taiwan Blood Cancer Detection Revenue Growth 2018-2023 ($ Millions)
Figure 56. Europe Blood Cancer Detection Sales Market Share by Country in 2022
Figure 57. Europe Blood Cancer Detection Revenue Market Share by Country in 2022
Figure 58. Europe Blood Cancer Detection Sales Market Share by Type (2018-2023)
Figure 59. Europe Blood Cancer Detection Sales Market Share by Application (2018-2023)
Figure 60. Germany Blood Cancer Detection Revenue Growth 2018-2023 ($ Millions)
Figure 61. France Blood Cancer Detection Revenue Growth 2018-2023 ($ Millions)
Figure 62. UK Blood Cancer Detection Revenue Growth 2018-2023 ($ Millions)
Figure 63. Italy Blood Cancer Detection Revenue Growth 2018-2023 ($ Millions)
Figure 64. Russia Blood Cancer Detection Revenue Growth 2018-2023 ($ Millions)
Figure 65. Middle East & Africa Blood Cancer Detection Sales Market Share by Country in 2022
Figure 66. Middle East & Africa Blood Cancer Detection Revenue Market Share by Country in 2022
Figure 67. Middle East & Africa Blood Cancer Detection Sales Market Share by Type (2018-2023)
Figure 68. Middle East & Africa Blood Cancer Detection Sales Market Share by Application (2018-2023)
Figure 69. Egypt Blood Cancer Detection Revenue Growth 2018-2023 ($ Millions)
Figure 70. South Africa Blood Cancer Detection Revenue Growth 2018-2023 ($ Millions)
Figure 71. Israel Blood Cancer Detection Revenue Growth 2018-2023 ($ Millions)
Figure 72. Turkey Blood Cancer Detection Revenue Growth 2018-2023 ($ Millions)
Figure 73. GCC Country Blood Cancer Detection Revenue Growth 2018-2023 ($ Millions)
Figure 74. Manufacturing Cost Structure Analysis of Blood Cancer Detection in 2022
Figure 75. Manufacturing Process Analysis of Blood Cancer Detection
Figure 76. Industry Chain Structure of Blood Cancer Detection
Figure 77. Channels of Distribution
Figure 78. Global Blood Cancer Detection Sales Market Forecast by Region (2024-2029)
Figure 79. Global Blood Cancer Detection Revenue Market Share Forecast by Region (2024-2029)
Figure 80. Global Blood Cancer Detection Sales Market Share Forecast by Type (2024-2029)
Figure 81. Global Blood Cancer Detection Revenue Market Share Forecast by Type (2024-2029)
Figure 82. Global Blood Cancer Detection Sales Market Share Forecast by Application (2024-2029)
Figure 83. Global Blood Cancer Detection Revenue Market Share Forecast by Application (2024-2029)


★調査レポート[世界の血液がん検出装置市場予測 2023年-2029年] (コード：LP23DC03166)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の血液がん検出装置市場予測 2023年-2029年]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界の血球抽出装置市場予測 2023年-2029年
  • 世界の血中脂質分析装置市場予測 2023年-2029年
  • 世界のブラッドウォーマー市場予測 2023年-2029年
  • 世界の滅菌静脈採血管市場予測 2023年-2029年
  • 世界のバキュテナー静脈採血管市場予測 2023年-2029年

    • ◆H&Iグローバルリサーチのお客様（例）◆